Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | integrin, alpha V | Starlite/ChEMBL | References |
Homo sapiens | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Starlite/ChEMBL | References |
Homo sapiens | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | integrin alpha ps | integrin, alpha V | 1002 aa | 908 aa | 22.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 0.2129 | 1 | 0.5 | |
Brugia malayi | Kelch motif family protein | 0.0311 | 0.0836 | 0.0649 |
Schistosoma mansoni | integrin beta subunit | 0.1204 | 0.534 | 0.5245 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.2129 | 1 | 1 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.2129 | 1 | 1 |
Brugia malayi | Integrin beta pat-3 precursor | 0.2045 | 0.9579 | 0.957 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.2129 | 1 | 1 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2129 | 1 | 1 |
Loa Loa (eye worm) | integrin beta-2 | 0.2045 | 0.9579 | 0.9579 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.2129 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0311 | 0.0836 | 0.0649 |
Loa Loa (eye worm) | hypothetical protein | 0.0311 | 0.0836 | 0.0836 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2129 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.2129 | 1 | 1 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0285 | 0.0704 | 0.0704 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0311 | 0.0836 | 0.0836 |
Toxoplasma gondii | fructose-bisphospatase II | 0.2129 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.001 uM | Binding affinity to integrin alpha5beta1 | ChEMBL. | 22575869 |
IC50 (functional) | = 0.01 uM | Antagonist activity at integrin alpha5beta1 in human K562 cells assessed as inhibition of cell adhesion | ChEMBL. | 22575869 |
IC50 (functional) | = 0.017 uM | Antagonist activity at integrin alphavbeta3 in human A375M cells assessed as inhibition of cell adhesion to fibrinogen in presence of Mg2+ | ChEMBL. | 22575869 |
IC50 (functional) | = 0.13 uM | Antagonist activity at integrin alpha5beta1 in human A375M cells assessed as inhibition of cell adhesion to fibronectin in presence of Mg2+ and MK-0429 | ChEMBL. | 22575869 |
IC50 (functional) | = 0.27 uM | Antagonist activity at integrin alphavbeta3alpha5beta1 in human A375M cells assessed as inhibition of cell adhesion to fibronectin in presence of Mg2+ | ChEMBL. | 22575869 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.